Aggrenox: 27 Clinical Trials, Page 1 of 3

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.

Bioequivalence of a New Asasantin Formulation Extended Release (ER) Compared to the Commercially Available Asasantin Formulation (Aggrenox®; Extended Release) in Healthy Male and Female Volunteers

Aggrenox To Treat Acute Covid-19

Drug-drug Interaction Study of Aggrenox and Omeprazole in Normal Volunteers

Study to Compare the Effect of a Combination of Dipyridamole With Sustained Release and Acetyl Salicylic Acid (Aggrenox®) on the Performance Relevant to Safety and on the General Condition of Healthy Volunteers

JASAP: Japanese Aggrenox Stroke Prevention vs. Aspirin Programme

Pharmacokinetics of Dipyridamole Administered as Aggrenox® (Dipyridamole Extended Release Plus Aspirin) Capsule Versus Dipyridamole Immediate Release Plus Aspirin Following Alteration of Stomach pH

Headache Study to Compare Aggrenox Full Dose and Reduced Dose

EARLY 3-months Aggrenox Treatment Started Within 24 Hrs of Ischemic Stroke Onset vs. After One Week 100 mg ASA

Aggrenox Prevention of Access Stenosis

Impact of Food on Pharmacokinetics and Pharmacodynamics of Asasantin ER in Healthy Subjects

Clinical Trials by Category

Clinical Trials Alphabetically

About

Bioequivalence of a New Asasantin Formulation Extended Release (ER) Compared to the Commercially Available Asasantin Formulation (Aggrenox^®; Extended Release) in Healthy Male and Female Volunteers

Study to Compare the Effect of a Combination of Dipyridamole With Sustained Release and Acetyl Salicylic Acid (Aggrenox^®) on the Performance Relevant to Safety and on the General Condition of Healthy Volunteers

Pharmacokinetics of Dipyridamole Administered as Aggrenox^® (Dipyridamole Extended Release Plus Aspirin) Capsule Versus Dipyridamole Immediate Release Plus Aspirin Following Alteration of Stomach pH